Mark S. Gelder M.D. is CHIEF MEDICAL OFFICER at Onconova Therapeutics, Inc. (ONTX). They have made 1 open-market trade across 1 company since 2021, most recently 2023-02-07.
CIK 0001564390
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONTX | 11,729 | $108K |
Shares reported on the most recent Form 4, priced at the 2023-02-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONTX | BUY | 2021-09-28 | 2021-09-29 | $4.20 | $10K | -4.7% | -10.1% | -34.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.